Page 91 - IJB-10-5
P. 91

International Journal of Bioprinting                            dECM bioink for 3D musculoskeletal tissue reg.




            compared to the control group of hTMSCs embedded in   dECM bioinks (PVA-A/SDCM [solubilized decellularized
            collagen (Figure 9A). Although the mechanical strength and   cartilage  matrix]  bioink,   cdECM-MA  bioinks, 136,183
                                                                                    135
            biological behavior of the constructs were not measured,   aptamer-GE  [GelMA/DCECM]  bioink,  PVA/dECM
                                                                                                184
            the potential of cdECM bioinks for cartilage tissue   bioink,   GelHACS  [hyaluronic  acid  and  chondroitin
                                                                    137
            regeneration has been validated. 24,182  Chae et al. developed a   sulfate]-MA bioink ) for cartilage bioprinting (Figure 9B).
                                                                              32
            computer-aided design (CAD)-based 3D-printed meniscus
            structure using a blend of polyurethane (PU)-PCL cell-  To mitigate the potential toxicity from bioink
            laden meniscal dECM (me-dECM) bioink. The printed   crosslinking (ion crosslinking, photocrosslinking, enzyme
                                                                                                 147
            constructs displayed excellent mechanical properties   crosslinking) and preserve cell viability,  Yang et al.
            and good biocompatibility, promoting the formation of   developed silk fibroin (SF)-dECM bioinks that do not
            fibrocartilage  via  proliferation  and  differentiation.  To   require crosslinkers. Instead, they utilized a method
            enhance cell viability, bioprintability, and mechanical   involving PEG to avoid crosslinking agents and leaching
            properties, researchers have developed various composite   processes. The scaffolds prepared from SF-dECM bioink














































            Figure 8. Bone regeneration with decellularized extracellular matrix (dECM) bioink. (A) Alg/MA-dECM composite bioink for bone tissue engineering.
            (A, i) Optical and DAPI/phalloidin fluorescence images of the Alg and Alg/2Ma-dECM scaffolds after 7 days; (A, ii) Immunofluorescence images of
            osteopontin in Alg and Alg/2Ma-dECM cells after 21 days of culture. Adapted with permission from Lee et al.  (B) GEL composite scaffolds: fluorescence
                                                                                 129
            microscopy images of MC3T3 cells cultured for 14 days. Adapted from Kara et al.  (C) Images of the 3D-printed hybrid scaffolds comprised of decellularized
                                                              64
            bone matrix particles combined with poly(caprolactone) (PCL). Adapted from Huang et al.  (D) DAPI/phalloidin/OPN staining of hASCs cultured on
                                                                      177
            mixed scaffolds of decellularized bone ECM (dbECM) and HA/PLLA. Adapted with permission from Hwangbo et al.  Abbreviations: Alg/MA-dECM,
                                                                                       132
            alginate and methacrylated dECM (Ma-dECM) ; GEL, gelatin; HA/PLLA, hydroxyapatite (HA) Poly (L-lactic acid) (PLLA); n.d., no data; HP: HA/PLLA n
            situ plasma-treated nHA/PLLA (is-HP); In situ plasma/thermal annealed nHA/PLLA (ist-HP).

            Volume 10 Issue 5 (2024)                        83                                doi: 10.36922/ijb.3418
   86   87   88   89   90   91   92   93   94   95   96